PharmX Technologies Valuation

Is PHX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PHX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate PHX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PHX's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHX?

Key metric: As PHX is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PHX. This is calculated by dividing PHX's market cap by their current revenue.
What is PHX's PS Ratio?
PS Ratio	5.1x
Sales	AU$8.09m
Market Cap	AU$41.30m

PHX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.5x
Enterprise Value/EBITDA	53.6x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does PHX's PS Ratio compare to its peers?

The above table shows the PS ratio for PHX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.2x
XF1 Xref	2x	n/a	AU$40.7m
3DP Pointerra	5.1x	56.6%	AU$32.3m
ADA Adacel Technologies	0.6x	10.2%	AU$29.8m
RKN Reckon	1.2x	5.7%	AU$64.0m
PHX PharmX Technologies	5.1x	n/a	AU$41.3m

Price-To-Sales vs Peers: PHX is expensive based on its Price-To-Sales Ratio (5.1x) compared to the peer average (2.2x).

Price to Sales Ratio vs Industry

How does PHX's PS Ratio compare vs other companies in the AU Software Industry?

14 Companies	Price / Sales	Estimated Growth	Market Cap
ADA Adacel Technologies	0.6x	10.2%	US$19.34m
MOQ MOQ	0.3x	n/a	US$15.57m
DUB Dubber	0.4x	n/a	US$10.23m
NOV Novatti Group	0.3x	9.4%	US$8.45m

14 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: PHX is expensive based on its Price-To-Sales Ratio (5.1x) compared to the Australian Software industry average (3.1x).

Price to Sales Ratio vs Fair Ratio

What is PHX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	5.1x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate PHX's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Pureprofile

AU$38.3m

A data and insights organization, engages in the provision of online research solutions for agencies, marketers, researchers, publishers, and brands and businesses in Australasia, Europe, and the United States.

PPL

AU$0.033

10.0%

13.8%

Bigtincan Holdings

AU$152.0m

Develops software for sales enablement market in Australia, the United States, and internationally.

BTH

AU$0.18

12.1%

2.8%

COSOL

AU$170.4m

Provides information technology services in the Asia Pacific, North America, Europe, the Middle East, Africa, and internationally.

COS

AU$0.95

14.5%

12.4%